共 158 条
[1]
Hendlin D(1969)Phosphonomycin, a new antibiotic produced by strains of streptomyces Science. 166 122-123
[2]
Stapley EO(1996)Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin Structure. 4 1465-1474
[3]
Jackson M(2013)Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10 J Antibiot (Tokyo) 66 625-627
[4]
Wallick H(2015)Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin Int Urol Nephrol 47 1059-1066
[5]
Miller AK(2013)Clinical Fosfomycin susceptibility of isolates with blaKPC-2 from Brazil J Inf Secur 67 247-249
[6]
Wolf FJ(2014)Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis Pediatr Pulmonol 49 230-237
[7]
Skarzynski T(2013)Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents Antimicrob Agents Chemother 57 1518-1520
[8]
Mistry A(2019)A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains BMC Pharmacol Toxicol 20 25-701
[9]
Wonacott A(2012)Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates Eur J Clin Microbiol Infect Dis 31 695-532
[10]
Hutchinson SE(1998)Staphylococcus aureus infections N Engl J Med 339 520-651